US Patent 7256024 Tyrissamycin antibiotic
Patent 7256024 was granted and assigned to Bristol-Myers Squibb on August, 2007 by the United States Patent and Trademark Office.
All edits
Edits on 1 Sep, 2023
Golden AI
Edits made to:
Article (+307 characters)
Article
Patent abstract
A novel tyrosyl diester antibiotic is obtained from fermentation of a recombinant strain of Streptomyces lividans designated Stretomyces lividans WD 15684 (ATCC-202143). The new antibiotic, designated tyrissamycin, exhibits antibacterial activity, particularly against gram-positive bacteria.
Edits on 22 Jul, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 21 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07256024 Tyrissamycin antibiotic US Patent 7256024 Tyrissamycin antibiotic
Infobox
Patent Number
0725602400
Patent Number
725602400
Edits on 24 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
072560240
Date of Patent
August 14, 2007
0Patent Application Number
108918880
Date Filed
November 18, 2004
0Official Website
Patent Primary Examiner
Edits on 23 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
072560240
Date of Patent
August 14, 2007
0Patent Application Number
108918880
Date Filed
November 18, 2004
0Official Website
Patent Primary Examiner
Edits on 16 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 22 Nov, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07256024 Tyrissamycin antibiotic
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07256024
Date of patent
August 14, 2007
Patent application number
10891888
Date Filed
November 18, 2004
Patent primary examiner
Find more entities like US Patent 7256024 Tyrissamycin antibiotic
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
